TARGETED CATALYTIC COMPLEMENT-ACTIVATING MOLECULES FOR TREATMENT OF EMERGING AND WHO PRIORITY BACTERIAL AND FUNGAL PATHOGENS Grant

Overview

date/time interval

April 1, 2023 - April 30, 2023

awarded by

Omeros Corporation

administered by

Medicine-Infectious Diseases

sponsor award ID

SRA 230269-01

Affiliation

contributor

Petraitiene, Ruta Co-Investigator 2023 - 2023
Petraitis, Vidmantas Principal Investigator 2023 - 2023